The Curious Case of the Grey-Market Mushroom Edibles: why “magic mushroom” gummies and bars are risky and often unlabeled

Grey-market mushroom edibles are fueling a surge in “magic mushroom” products sold in smoke shops and gas stations, often with unclear contents and serious safety implications. The piece argues that Amanita muscaria products (including muscimol and ibotenic acid) have become widely used in part because legality and branding make them more accessible than psilocybin mushrooms. It contrasts the longer dream-like delirium and physical side effects described for Amanitas with psilocybin’s broader reputation for mental health benefits. A central concern is drug policy and enforcement: the author ties the rise of mystery gummies and chocolate bars to the Federal Analogue Act and a “grey market” of designer chemicals. They claim some products may contain unverified research-chemical alternatives such as 4-AcO-DMT and other related compounds, while products are labeled deceptively as “magic mushrooms.” The post also highlights how youth-oriented branding and online communities of consumers trying to reverse-engineer ingredients increase exposure risk, and recounts an on-the-ground attempt in Portland, Oregon to trace what vendors actually know about these edibles.